33386 Federal Register / Vol. 72, No.

116 / Monday, June 18, 2007 / Rules and Regulations

235); Sec. 2455, Pub. L. 103–355, 108 Stat.
3327 (31 U.S.C. 6101 note); 5 U.S.C. 301;
U.S.C. 6101 note.
§ 12.75 [Removed]
■ 3. Remove § 12.75.
§ 12.913 [Removed]
■ 4. Remove § 12.913.
PART 42—GOVERNMENTWIDE
DEBARMENT AND SUSPENSION
(NONPROCUREMENT) [REMOVED]
■ 5. Remove part 42.
PART 43—GOVERNMENTWIDE
REQUIREMENTS FOR DRUG-FREE
WORKPLACE (FINANCIAL
ASSISTANCE)
■ 6. The authority for part 43 continues
to read as follows:
Authority: E.O. 12549 (3 CFR, 1986 Comp.,
p. 189); E.O. 12689 (3 CFR, 1989 Comp., p.
235); Sec. 2455, Pub. L. 103–355, 108 Stat.
3327 (31 U.S.C. 6101 note); 5 U.S.C. 301; 31
U.S.C.
§ 43.510 [Amended]
■ 7. Amend § 43.510(c) by removing the
citation ‘‘43 CFR Part 42’’ and adding ‘‘2
CFR Part 180’’ in its place.
§ 43.630 [Amended]
■ 8. Amend § 43.630 by removing the
phrase ‘‘the common rule, Government-
wide Debarment and Suspension
(Nonprocurement), that implements
Executive Order 12549 and Executive
Order 12689’’ and adding the citation ‘‘2
CFR part 180’’ in its place.
§ 43.670 [Amended]
■ 9. Amend § 43.670 by removing the
phrase ‘‘the common rule, Government-
wide Debarment and Suspension
(Nonprocurement), that implements
Executive Order 12549 and Executive
Order 12689’’ and adding the citation ‘‘2
CFR part 180’’ in its place.
[FR Doc. 07–2949 Filed 6–15–07; 8:45 am]
BILLING CODE 4310–RF–M
regulations to update a telephone
number for the Office of Information
Services and an NRC Web site location.
This document is necessary to inform
the public of these changes to the NRC’s
regulations.
EFFECTIVE DATE: June 18, 2007.
FOR FURTHER INFORMATION CONTACT:
Thomas Smith, Office of Information
Services, Nuclear Regulatory
Commission, Washington, DC 20555–
0001, 301–415–7043, e-mail
TES@nrc.gov.
SUPPLEMENTARY INFORMATION: The NRC
is revising its regulations to update a
telephone number for the Office of
Information Services and an NRC Web
site location. The Web site contains
detailed guidance on making electronic
submissions to the agency. This
guidance discusses, among other topics,
the formats the NRC can accept, the use
of electronic signatures, and the
treatment of nonpublic information.
Environmental Impact: Categorical
Exclusion
The NRC has determined that this
final rule is the type of action described
in categorical exclusion 10 CFR
51.22(c)(1) and (2). Therefore, neither an
environmental impact statement nor an
environmental assessment has been
prepared for this final rule.
Paperwork Reduction Act Statement
This final rule does not contain a new
or amended information collection
requirement subject to the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.).
Public Protection Notification
If a means used to impose an
information collection does not display
a currently valid OMB control number,
the NRC may not conduct or sponsor,
and a person is not required to respond
to, the information collection.
Regulatory Analysis
A regulatory analysis has not been
prepared for this final rule. This final
Congressional Review Act
In accordance with the Congressional
Review Act, the NRC has determined
that this action is not a major rule and
has verified this determination with the
Office of Information and Regulatory
Affairs of OMB.
Because these amendments deal
solely with agency organization and
procedure, and represent minor
administrative matters which do not
raise any significant policy or regulatory
issue, the NRC has determined that
notice and comment is not necessary
under the Administrative Procedure Act
(APA), 5 U.S.C. 553(b)(3)(A), and that in
any event there is good cause for
dispensing with such notice and
comment under 5 U.S.C. 553(d)(3)(B). In
addition, the NRC has determined that
good cause exists for making the rule
immediately effective upon publication,
as provided for under 5 U.S.C. 553(d)(3),
because the amendments represent
minor administrative matters which do
not raise any significant policy or
regulatory issue and do not impose any
significant regulatory requirement upon
any regulated entity or person.
■ For the reasons set out in the
preamble and under the authority of the
Atomic Energy Act of 1954, as amended,
the Energy Reorganization Act of 1974,
as amended, and 5 U.S.C. 552 and 553,
42 U.S.C. 2201, as amended, and 42
U.S.C. 5841, the NRC is adopting the
following amendments to 10 CFR
Chapter I to read as follows:
10 CFR Chapter I [Amended]
■ 1. In Chapter I revise all references to
‘‘(301) 415–6030’’ to read ‘‘(301) 415–
0439’’.
■ 2. In Chapter I revise all references to
‘‘http://www.nrc.gov/site-help/eie.html’’
to read ‘‘http://www.nrc.gov/site-help/
e-submittals.html’’.
Dated at Rockville, Maryland, this 4th day
of June, 2007.
For the Nuclear Regulatory Commission.
Luis A. Reyes,
Executive Director for Operations.
[FR Doc. E7–11708 Filed 6–15–07; 8:45 am]

NUCLEAR REGULATORY rule makes only minor administrative BILLING CODE 7590–01–P

COMMISSION changes to the regulations that reference

a telephone number and an NRC Web
10 CFR Chapter I site, and imposes no burden on DEPARTMENT OF HEALTH AND
licensees. Therefore, a regulatory HUMAN SERVICES
RIN 3150–AI18 analysis is not necessary.
Food and Drug Administration
Administrative Changes Backfit Analysis
AGENCY: Nuclear Regulatory The NRC has determined that these 21 CFR Part 558
pwalker on PROD1PC71 with RULES

Commission. amendments do not involve any

ACTION: Final rule.
SUMMARY: The Nuclear Regulatory
Commission (NRC) is amending its
New Animal Drugs for Use in Animal
provisions which would impose backfits
Feeds; Lincomycin
as defined in 10 CFR 50.109(a)(1);
therefore a backfit analysis is not AGENCY: Food and Drug Administration,
necessary. HHS.

VerDate Aug<31>2005 17:03 Jun 15, 2007 Jkt 211001 PO 00000 Frm 00004 Fmt 4700 Sfmt 4700 E:\FR\FM\18JNR1.SGM 18JNR1
 Federal Register / Vol. 72, No. 116 / Monday, June 18, 2007 / Rules and Regulations
ACTION: Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect
approval of a supplemental new animal
drug application (NADA) filed by
Pharmacia & Upjohn Co., a Div. of
Pfizer, Inc. The supplemental NADA
provides for the use of lincomycin in
feed of swine weighing greater than 250
pounds and for the addition of a
reproductive cautionary statement to
labeling.
DATES: This rule is effective June 18,
2007.
FOR FURTHER INFORMATION CONTACT:
C. Gotthardt, Center for Veterinary
Medicine (HFV–130), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301–827–7571, e-
mail: joan.gotthardt@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pharmacia
& Upjohn Co., a Div. of Pfizer, Inc., 235
E. 42d St., New York, NY 10017, filed
a supplement to NADA 97–505 that
provides for use of LINCOMIX 20
(lincomycin hydrochloride) and
LINCOMIX 50 Feed Medications in
single-ingredient Type B and Type C
medicated feeds for swine weighing
greater than 250 pounds and for the
addition of a reproductive caution
statement to labeling. The supplemental
application is approved as of May 23,
2007, and the regulations are amended
in 21 CFR 558.325 to reflect the
approval.
Approval of this supplemental NADA
did not require review of additional
safety or effectiveness data or
information. Therefore, a freedom of
information summary is not required.
The agency has determined under 21
CFR 25.33(a)(1) that this action is of a
type that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
List of Subjects in 21 CFR Part 558
Animal drugs, Animal feeds.
■ Therefore, under the Federal Food,
pwalker on PROD1PC71 with RULES
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 558 is amended as follows:
VerDate Aug<31>2005 17:03 Jun 15, 2007 Jkt 211001
PART 558—NEW ANIMAL DRUGS FOR
USE IN ANIMAL FEEDS
■ 1. The authority citation for 21 CFR
part 558 continues to read as follows:
Authority: 21 U.S.C. 360b, 371.
■ 2. In § 558.325, add paragraph (c) and
in the table in paragraphs (d)(2)(i)
through (d)(2)(iv), in the ‘‘Limitations’’
column, remove ‘‘Not to be fed to swine
that weigh more than 250 lb.’’ wherever
it occurs to read as follows:
§ 558.325 Lincomycin.
* * * * *
Joan (c) Special considerations—(1)
Labeling of Type A medicated articles
and Type B and Type C medicated feeds
containing lincomycin shall bear the
following directions: ‘‘CAUTION: Do
not allow rabbits, hamsters, guinea pigs,
horses, or ruminants access to feeds
containing lincomycin. Ingestion by
these species may result in severe
gastrointestinal effects.’’
(2) Labeling of Type A medicated
articles and Type B and Type C
medicated feeds containing lincomycin
intended for use in swine shall bear the
following directions: ‘‘CAUTION:
Occasionally, swine fed lincomycin may
within the first 2 days after the onset of
treatment develop diarrhea and/or
swelling of the anus. On rare occasions,
some pigs may show reddening of the
skin and irritable behavior. These
conditions have been self-correcting
within 5 to 8 days without
discontinuing the lincomycin
treatment.’’
(3) Labeling of Type A medicated
articles and single-ingredient Type B
and Type C medicated feeds containing
lincomycin intended for use in swine
shall bear the following directions:
(i) No. 000009: ‘‘CAUTION: The
effects of lincomycin on swine
reproductive performance, pregnancy,
and lactation have not been determined.
Not for use in swine intended for
breeding when lincomycin is fed at 20
grams per ton of complete feed.’’
(ii) Nos. 043733 and 051311:
‘‘CAUTION: Not to be fed to swine that
weigh more than 250 lb.’’
* * * * * Summary of Comments
Dated: June 8, 2007.
Steven D. Vaughn,
Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. E7–11611 Filed 6–15–07; 8:45 am]
BILLING CODE 4160–01–S
PO 00000 Frm 00005 Fmt 4700 Sfmt 4700 E:\FR\FM\18JNR1.SGM
33387
DEPARTMENT OF THE TREASURY
Internal Revenue Service
26 CFR Part 1
[TD 9331]
RIN 1545–BG46
Deemed IRAs in Governmental Plans/
Qualified Nonbank Trustee Rules
AGENCY: Internal Revenue Service (IRS),
Treasury.
ACTION: Final regulations and removal of
temporary regulations.
SUMMARY: This document contains final
regulations under section 408 of the
Internal Revenue Code. The final
regulations provide special rules for a
governmental unit which seeks to
qualify as a nonbank trustee of a
deemed IRA that is part of its qualified
employer plan. These final regulations
affect only such governmental units.
DATES: Effective Date: June 18, 2007.
Applicability Date: For dates of
applicability, see § 1.408–2(e)(8)(iv).
FOR FURTHER INFORMATION CONTACT:
Linda L. Conway, 202–622–6090, or
Cathy A. Vohs, 202–622–6090 (not toll-
free numbers).
SUPPLEMENTARY INFORMATION:
Background
This document contains final
amendments to the Income Tax
Regulations (26 CFR Part 1) under
section 408 of the Internal Revenue
Code of 1986 (Code). On July 22, 2004,
temporary and proposed regulations
under section 408 were issued. A notice
of proposed rulemaking (REG–101447–
04) was published in the Federal
Register (69 FR 43786). The text of the
temporary regulations also served as the
text of the proposed regulations. The
text of temporary § 1.408–2(e)(8) was
published in the same issue of the
Federal Register (69 FR 43735). The RIN
published in connection with that
notice of proposed rulemaking was
1545–BD07. However, due to technical
difficulties that RIN is no longer valid
and the RIN number of these final
regulations is 1545–BG46. No comments
were received regarding the proposed
regulations.
Explanation of Provisions and
These final regulations amend
§ 1.408–2(e) of the regulations to
provide that a governmental unit may
serve as the trustee of any deemed IRA
established by that governmental unit as
part of its qualified employer plan if
that governmental unit establishes to the
18JNR1